MeiraGTx Operating Margin from 2010 to 2024

MGTX Stock  USD 6.33  0.40  6.75%   
MeiraGTx Holdings Operating Profit Margin yearly trend continues to be fairly stable with very little volatility. Operating Profit Margin will likely drop to -10.27 in 2024.
Check MeiraGTx Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MeiraGTx Holdings' main balance sheet or income statement drivers, such as Interest Income of 2.3 M, Depreciation And Amortization of 14.4 M or Interest Expense of 13.9 M, as well as many indicators such as Price To Sales Ratio of 35.48, Dividend Yield of 0.0 or PTB Ratio of 3.01. MeiraGTx financial statements analysis is a perfect complement when working with MeiraGTx Holdings Valuation or Volatility modules.
  
Check out the analysis of MeiraGTx Holdings Correlation against competitors.

Latest MeiraGTx Holdings' Operating Margin Growth Pattern

Below is the plot of the Operating Profit Margin of MeiraGTx Holdings PLC over the last few years. It is MeiraGTx Holdings' Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MeiraGTx Holdings' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (162.80) %10 Years Trend
Slightly volatile
   Operating Profit Margin   
       Timeline  

MeiraGTx Operating Margin Regression Statistics

Arithmetic Mean(5.14)
Coefficient Of Variation(43.39)
Mean Deviation1.59
Median(4.38)
Standard Deviation2.23
Sample Variance4.98
Range8.3286
R-Value(0.55)
Mean Square Error3.72
R-Squared0.31
Significance0.03
Slope(0.28)
Total Sum of Squares69.74

MeiraGTx Operating Margin History

2024 -10.27
2023 -9.78
2022 -7.31
2021 -1.94
2020 -4.02

About MeiraGTx Holdings Financial Statements

MeiraGTx Holdings investors use historical fundamental indicators, such as MeiraGTx Holdings' Operating Margin, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MeiraGTx Holdings. Please read more on our technical analysis and fundamental analysis pages.
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York. MeiraGTx Holdings operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 333 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for MeiraGTx Stock Analysis

When running MeiraGTx Holdings' price analysis, check to measure MeiraGTx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MeiraGTx Holdings is operating at the current time. Most of MeiraGTx Holdings' value examination focuses on studying past and present price action to predict the probability of MeiraGTx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MeiraGTx Holdings' price. Additionally, you may evaluate how the addition of MeiraGTx Holdings to your portfolios can decrease your overall portfolio volatility.